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Objective. Epidemiologic studies suggest an inverse relationship between nonalcoholic fatty liver disease (NAFLD), visceral adipose
tissue (VAT), and self-reported physical activity levels. However, subjective measurements can be inaccurate and prone to reporter
bias. We investigated whether objectively quantified physical activity levels predicted liver fat and VAT in overweight/obese adults.
Methods. Habitual physical activity wasmeasured by triaxial accelerometry for four days (𝑛 = 82). Time spent in sedentary behavior
(MET < 1.6) and light (MET 1.6 < 3), moderate (MET 3 < 6), and vigorous (MET 6 < 9) physical activity was quantified. Magnetic
resonance imaging and spectroscopy were used to quantify visceral and liver fat. Bivariate correlations and hierarchical multiple
regression analyses were performed. Results. There were no associations between physical activity or sedentary behavior and liver
lipid. Sedentary behavior and moderate and vigorous physical activity accounted for just 3% of variance for VAT (𝑝 = 0.14) and
0.003% for liver fat (𝑝 = 0.96). Higher levels of VAT were associated with time spent in moderate activity (𝑟 = 0.294, 𝑝 = 0.007),
but there was no association with sedentary behavior. Known risk factors for obesity-related NAFLD accounted for 62% and 40%
of variance in VAT and liver fat, respectively (𝑝 < 0.01). Conclusion. Objectively measured levels of habitual physical activity and
sedentary behavior did not influence VAT or liver fat.
1. Introduction
The benefits of regular structured exercise are well docu-
mented and include improvements in cardiovascular and
metabolic function, which reduce the risk of chronic health
conditions such as type 2 diabetes and cardiovascular disease
[1]. Recent evidence also demonstrates that exercise alone
(in the absence of concomitant dietary restriction) reduces
visceral adipose tissue (VAT) [2] and intrahepatic lipid (IHL)
[3–5], both of which are independently associated with
cardiovascular and metabolic risk [6]. While there is strong
evidence for the benefits of regular structured exercise (i.e.,
exercise which is planned and involves repetitivemovement),
it is currently unclear whether increased levels of habitual
activity (activity that is unstructured and accumulated during
daily activities outside of structured exercise) and reduced
sedentary behavior (activity with low metabolic rate (<1.6
METS) and in a reclining or seated position) have similar
health benefits in the reduction of these adipose tissue depots.
Understanding such associations has implications for policy
as, because of low participation rates in structured exercise
[7], there is an increasing emphasis in public health messages
on the importance of habitual physical activity levels and
reduced sedentary time [8].
Cross-sectional analyses indicate an inverse relationship
between central adiposity as inferred by waist circumference
[9], dual energy X-ray absorptiometry [10], or computed
tomography (CT) [11] and self-reported physical activity
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levels. A similar inverse relationship has been observed for
nonalcoholic fatty liver disease (NAFLD) [12–14]. Prospective
studies have further supported this association [15–17]. In
the Finnish Twin Cohort (TWINACTIVE) study, physically
inactive cotwins were found to have liver fat scores (assessed
via difference in mean signal intensity from magnetic reso-
nance imaging) 170% greater than that of their active cotwin
[17], and habitual physical activity, performed outside of work
hours, was the strongest correlate of central abdominal fat
after controlling for both environmental and genetic factors
[18]. However, self-reported behavior is subject to reporter
bias and tends to overestimate activity levels [19], especially in
overweight and obese populations [20]. Emerging evidence
using objectively measured physical activity via accelerom-
etry supports these observations [21–24]; however research
using accurate assessments of VAT and IHL is limited.
If the above epidemiological data [11–14] can be con-
firmed by high quality objective assessments, encouraging
habitual physical activity and reducing sedentary behavior
will have important clinical ramifications. Hence, in this
study, we aimed to evaluate whether levels of accurately
quantified sedentary behavior and habitual physical activity
could predict levels of VAT and IHL in adults with over-
weight/obesity. Based on current guidelines for the manage-
ment of obesity which recommend high volumes ofmoderate
intensity activity [25], we hypothesised that there would
be a negative relationship between time spent in moderate
intensity physical activity and levels of VAT and IHL and a
positive relationship between time spent in sedentary behav-
ior and VAT and IHL content. Furthermore, we hypothesised
that levels of sedentary behavior and moderate physical
activity would explain a significant proportion of variance
in VAT and IHL when modelled with known obesity-related
health risk factors (including age, sex, body mass index
(BMI), waist circumference, fasting glucose, fasting insulin,
high density lipoprotein cholesterol, triglycerides, and resting
blood pressure).
2. Methods
2.1. Participants. Participants were recruited via notice-
boards, electronic bulletins, and clinical databases between
June 2011 and January 2015 from a community-based sample
of adult men and women (aged 18–60 years) with overweight
or obesity (BMI ≥ 25.0 kg⋅m−2). Volunteers were excluded
if they reported being physically active (exercising >3 days
per week or meeting current guidelines for physical activity
[1]) or were cigarette smokers. Participants provided clear-
ance for participation from a medical practitioner prior to
involvement and were excluded if there was evidence of
an unstable cardiac condition, type 2 diabetes, hyperten-
sion, or liver disease other than nonalcoholic fatty liver
disease (NAFLD) or secondary causes of steatohepatitis.
Other exclusion criteria included taking lipid-lowering or
insulin sensitizing medication, reporting taking 𝑛-3 polyun-
saturated fatty acids within the last 6 months, or a change in
medication within the last 12 months, regular alcohol con-
sumption >20 g/day, or a significant change in body weight
(>5% weight change) in the previous three months. The
analysis included 82 volunteers from larger intervention
trials (ANZCTRN12610000351011; ACTRN12614000723684),
the results of which have been published elsewhere [5]. The
study conformed to the ethical guidelines of the 1975 Dec-
laration of Helsinki and was approved by The University of
Sydney Human Research Ethics Committee and the Sydney
Local Health District Ethics Review Committee. Eligible
participants were screened via telephone interview and those
meeting criteria provided informed consent and were invited
to attend baseline assessments which included measures of
anthropometry, a fasting blood test, magnetic resonance im-
aging (MRI) and spectroscopy (1H-MRS), and accelerometry.
2.2. Measurements
2.2.1. Anthropometry and Blood Pressure Assessment. Stature
was recorded by stadiometer (SECA model 220 Telescopic
Height Rod, Hamburg, Germany). Weight was measured
(Tanita BC-418 Body Composition Analyzer; Tanita Corpo-
ration, Tokyo, Japan) to the nearest 0.1 kg and BMI (kg⋅m−2)
was calculated. Waist circumference was measured in trip-
licate at the horizontal plane, midway between the inferior
margin of the ribs and the superior boarder of the iliac crest
at end-expiration. Systolic (SBP) and diastolic (DBP) blood
pressure were measured manually on each arm, after 10–
15min of quiet sitting.
2.2.2. Biochemical Parameters. Venous blood was collected
from the antecubital vein after an overnight fast (>10 hours).
On the same day serum glucose, insulin, total cholesterol
(TC), triglycerides (TG), high density lipoprotein cholesterol
(HDL), low density lipoprotein cholesterol (LDL), alanine
aminotransferase (ALT), aspartate aminotransferase (AST),
and high sensitivity C-reactive protein (hs-CRP) were anal-
ysed by a commercially accredited laboratory.
2.2.3. Magnetic Resonance Imaging (MRI) and Proton Mag-
netic Resonance Spectroscopy (1H-MRS). Visceral adipose tis-
sue was assessed via MRI and intrahepatic lipid via 1H-MRS
using a 1.5 Tesla Achieva whole-body system (PhilipsMedical
Systems; Best, Netherlands) as previously outlined [5, 26].
The cross-sectional areas for abdominal VAT were analysed
using automated software (Hippo Fat) [27] with manual
editing as necessary. Total VAT volumes were calculated by
summation of slice areas with adjustment for slice thickness.
Liver spectra data were analysed by magnetic resonance
user interface software (jMRUI version 4.0, EU Project)
[26]. Hepatic water signal amplitude was measured from the
nonwater suppressed spectrum [5].
2.2.4. Objective Activity Monitoring. Current mean time
spent in physical activity, sedentary behavior, daily steps,
and energy expenditure were assessed by triaxial accelerom-
eter (SenseWear, BodyMedia Inc., PA, USA). Data were
collected from all participants for four days (3 weekdays
and 1 weekend, which was the minimum inclusion criteria)
for 24 hours per day, except during water-based activities
Journal of Obesity 3
including showering, bathing, or swimming. All data were
collected at least 7 days after magnetic resonance imaging.
Armbands were worn on the left upper arm. Participants
were instructed to continuewith their habitual routine during
this period. Physical activity levels and sedentary behavior
were quantified (BodyMedia software, v8.0) with sedentary
behavior defined as <1.6 METs, “light” activity as 1.6 <
3 METs, “moderate” activity as 3 < 6 METs, “vigorous”
activity as 6 < 9 METs, and “high” activity as ≥9 METs [28].
Sleep duration was not included in time spent in sedentary
behavior. Data were included if the monitor was worn for
>85% of a 24-hour day.
2.3. Statistical Analysis. All descriptive data are reported as
means ± standard error from the mean (SE). Differences
between groups were compared by Student’s 𝑡-test with
homogeneity of variances assessed via Levene’s test for equal-
ity of variance or 𝜒2 for categorical data. Pearson coefficients
(𝑅) were used for all correlations. Separate hierarchical
multiple regression analyses were performed for prediction
of VAT and IHL percentage. Simple anthropometric and
demographic variables were entered at Block 1 for both VAT
and IHL. Known cardiometabolic risk variables were entered
into the regression at Block 2, based on the variables that were
significantly associated with VAT and IHL, respectively, in
our sample (Table 2). These included TG, glucose, insulin,
SBP, DBP, ALT and BMI for VAT and glucose, insulin, ALT,
HDL, and BMI for IHL. While TG was not significantly
associated with VAT in our analysis, it was included given
its previously established association with excess VAT [29].
Finally, mean time spent in sedentary behavior, moderate
intensity activity, and vigorous intensity activity were entered
into Block 3 of the regression analysis. Data were analysed
using Statistical Package for the Social Sciences (SPSS version
22.0; IMB Corp., Armonk, NY, USA); 𝑝 values were based
on two-sided tests and considered statistically significant at
𝑝 < 0.05.
3. Results
3.1. Participants. Eighty-two adults (60% male) participated
in the study. Mean age was 40.1 ± 1.9 years, BMI 30.9 ±
0.5 kg⋅m−2, waist circumference 100.0 ± 1.1 cm, and liver
fat 5.3 ± 0.5%. Thirty-five percent of the participants were
classified as having NAFLD based on IHL > 5.5% [30].
Other participants’ characteristics are summarised in Table 1.
Mean device wear time was 97 ± 2% of a 24-hour day.
Participants with NAFLD had a significantly higher BMI,
waist circumference, SBP, VAT, fasting glucose, and fasting
insulin (𝑝 < 0.05). There were no differences in objectively
measured levels of physical activity, sedentary behavior, total
daily energy expenditure, or the number of steps taken
per day between participants with and without NAFLD
(Table 1). Time spent in high intensity activity (>9METS)was
negligible (mean 37±27 seconds) with only 3/82 participants
(4%) engaging in high intensity activity for more than an
average of one minute in total. When high intensity activity
was included in the analysis, the results were not altered (data
not shown).While there are no established critical thresholds
for VAT volume with respect to morbidity andmortality risk,
based on gender specific waist circumferences for Caucasian
populations, 51% of men and 73% of women were above the
risk threshold for abdominal obesity [31].
3.2. Bivariate Correlations. Bivariate correlations between
VAT and IHL and biochemical, anthropometric, and
accelerometry assessed activity variables are summarised
in Table 2. A higher volume of VAT was associated with
higher IHL, BMI, waist circumference, SBP, DBP, fasting
glucose, fasting insulin, and ALT (Table 2). There was a
weak association between higher levels of VAT and higher
amounts of moderate intensity physical activity (𝑟 = 0.294,
𝑝 = 0.007). Higher levels of IHL were associated with higher
BMI, waist circumference, VAT, fasting glucose, and fasting
insulin and lower levels of HDL, but there was no association
between IHL and total energy expended, time spent in
sedentary behavior, and time spent in any level of activity
(Table 2).
3.3. Hierarchical Multiple Regression Analysis. Demographic
and anthropometric variables (waist circumference, sex, and
age) accounted for 54% and 30% of the variance in VAT
and IHL, respectively (𝑝 < 0.001; Tables 3 and 4). The
addition of TG, glucose, insulin, SBP, DBP, and BMI in
Block 2 accounted for a further 9% of variance in VAT
(𝑝 = 0.032). The addition of glucose, HDL, ALT, insulin,
and BMI increased the prediction of IHL to 40%; however
this was not significant (𝑝 = 0.06). The addition of time
spent in sedentary behavior, moderate and vigorous intensity
activity (Block 3), increased the prediction of VAT to 65%
(𝑝 = 0.14) and did not change the prediction of IHL
(𝑝 = 0.96). Waist circumference, triglyceride, and fasting
glucose contributed significantly to the prediction of high
levels of VAT while waist circumference and fasting insulin
contributed significantly to the prediction of high levels of
IHL.
4. Discussion
We aimed to evaluate whether levels of accurately quanti-
fied sedentary behavior and habitual physical activity could
predict levels of visceral adiposity and liver fat. Surprisingly,
while traditional risk factors for cardiovascular disease (e.g.,
sex, age, and waist circumference) were associated with VAT
and IHL, no relationship was observed between objectively
measured physical inactivity and raised liver fat. Further, we
unexpectedly observed a weak positive association between
VAT volume and time spent in moderate activity (i.e.,
increased VAT was associated with higher time spent in
moderate intensity physical activity) and also total energy
expenditure. The inclusion of objectively measured levels of
moderate activity and sedentary behavior did not improve
the potency of traditional risk factors (waist circumference,
triglycerides, fasting glucose, or fasting insulin) for predicting
the liver fat concentration or level of visceral adiposity. As a
cross-sectional analysis, this study demonstrates that current
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Table 1: Participants’ characteristics.
Total group (𝑛 = 82) NAFLD (𝑛 = 29) Non-NAFLD (𝑛 = 53) 𝑝∗
Demographics and anthropometry
Age (years) 40.1 (1.9) 41.7 (2.3) 39.3 (1.4) 0.34
Sex (M/F) 49/33 18/11 31/22 0.75
BMI (kg⋅m−2) 30.9 (0.5) 32.7 (1.1) 29.9 (0.5) 0.02
Waist circumference (cm) 100.0 (1.1) 105.8 (2.0) 96.8 (1.2) <0.001
SBP (mmHg) 127.4 (1.5) 132.1 (2.7) 124.8 (1.8) 0.02
DBP (mmHg) 81.0 (0.8) 83.1 (1.3) 79.8 (1.0) 0.05
SAT (cm3) 9268 (405) 10431 (806) 8632 (427) 0.55
VAT (cm3) 3153 (169) 3847 (301) 2774 (185) 0.004
IHL (%) 5.3 (0.5) 10.3 (0.9) 2.6 (0.2) <0.001
Biochemistry
Glucose (mmol/L) 4.3 (0.1) 4.6 (0.1) 4.1 (0.1) <0.001
Insulin (mU/L) 8.4 (0.5) 10.6 (1.2) 7.2 (0.5) 0.01
ALT (U/L) 27.9 (1.5) 31.8 (2.2) 25.8 (1.8) 0.05
AST (U/L) 24.7 (1.1) 25.9 (1.8) 24.0 (1.3) 0.40
hsCRP (mg/L) 8.4 (0.5) 4.6 (0.9) 2.7 (0.4) 0.73
Lipids
Total cholesterol (mmol/L) 5.5 (0.1) 5.5 (0.2) 5.5 (0.1) 0.99
Triglyceride (mmol/L) 1.3 (0.1) 1.6 (0.2) 1.2 (0.1) 0.05
LDL (mmol/L) 3.5 (0.1) 3.5 (0.2) 3.5 (0.1) 0.99
HDL (mmol/L) 1.4 (0.0) 1.3 (0.1) 1.5 (0.0) 0.06
Habitual physical activity
Sedentary behavior (<1.6METs) (hours:min) 12:08 (0:12) 12:10 (0:20) 12:08 (0:16) 0.93
Light physical activity (1.6–2.9METs) (hours:min) 2:58 (0:06) 2:48 (0:11) 3:04 (0:07) 0.20
Moderate physical activity (3–5.9METs) (hours:min) 1:30 (0:07) 1:34 (0:15) 1:29 (0:06) 0.75
Vigorous physical activity (6–8.9METs) (hours:min) 0:05 (0:01) 0:04 (0:01) 0:06 (0:0) 0.39
Steps (per day) 8915 (355) 8855 (751) 8947 (371) 0.90
Total energy expenditure (kJ) 13061 (485) 13145 (541) 13015 (693) 0.90
M: male; F: female; BMI: body mass index; NAFLD: nonalcoholic fatty liver disease; SBP: systolic blood pressure; DBP: diastolic blood pressure; SAT:
subcutaneous adipose tissue; VAT: visceral adipose tissue; IHL: intrahepatic lipid; ALT: alanine aminotransferase; AST: aspartate aminotransferase; hsCRP:
high-sensitivity c-reactive protein; LDL: low density lipoprotein cholesterol; HDL: high density lipoprotein cholesterol; and METs: metabolic equivalents.
Values are mean (standard error). ∗𝑝 value for NAFLD versus non-NAFLD using Student’s 𝑡-test for continuous variables and 𝜒2 for categorical variables.
habitual activity levels are not related to VAT or liver fat;
however it does not account for lifetime levels of habitual
activity. Further, while objective assessment of activity via
accelerometry is considered more accurate than self-report
methods, participants may still have altered their usual
behavior during monitoring.While a significant reduction in
liver fat has been observed with just 4 weeks of structured
aerobic exercise [32], it is uncertain how long current habitual
activity patterns may take to affect VAT and liver fat.
On the basis of epidemiological data at the population
level, physical inactivity is associated with the development
of NAFLD [12–14] and visceral adiposity [11], and reducing
sedentary behavior (including sitting time) should be gener-
ally advocated in all populations and is now recognized in
public health messages [8]. However, our findings suggest
that objectively measured physical activity is not greatly
predictive of risk at an individual level and the associations
between habitual physical activity levels, sedentary behavior,
and metabolically detrimental fat depots such as VAT and
IHL remain uncertain. While our findings appear counter-
intuitive to epidemiological data, unlike these studies, we
accurately quantified both liver fat and VAT, as well as 24-
hour habitual physical activity behavior, suggesting that the
relationship may not be as straightforward.
There is now strong and consistent evidence that regular
structured physical activity (exercise training) reduces VAT
[2] and IHL [3–5]. This reflects current physical activity
guidelines which advocate structured exercise for health
benefits [1]. With the less potent stimulus of general habitual
activity, the volume of activity required for benefit is much
greater (e.g., the accumulation of >470min of physical
activity for weight loss [25]). While increasing incidental
activity is important for increasing total daily energy expen-
diture, there is an established dose potency of structured
exercise for a range of cardiovascular and metabolic health
risk variables [1]. Additionally, there are well-established
inverse relationships between cardiorespiratory fitness and
NAFLD [33], histological severity of liver disease [34], and
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Table 3: Hierarchical regression model for prediction of visceral adiposity.
𝑅 𝑅
2 Adjusted 𝑅2 𝑅2 change 𝑝 𝛽
Block 1 0.732 0.536 0.518 0.536 <0.001
Sex −0.251
Age 0.386
Waist 0.503
Block 2 0.790 0.624 0.571 0.087 0.032
Sex −0.148
Age 0.244
Waist 0.525
TG 0.264
SBP 0.029
DBP −0.36
ALT 0.052
BMI 0.001
Glucose 0.127
Insulin −0.094
Block 3 0.808 0.653 0.587 0.029 0.136
Sex −0.022
Age 0.194
Waist 0.510
TG 0.241
SBP −0.039
DBP −0.005
ALT 0.062
BMI 0.056
Glucose 0.174
Insulin −0.086
Sedentary −0.031
Moderate 0.212
Vigorous −0.023
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; ALT: alanine aminotransferase; and TG: triglyceride. Boldface indicates
statistical significance (𝑝 < 0.05).
VAT [35]. Indeed high levels of cardiorespiratory fitness is
a characteristic of the phenomenon termed “metabolically
healthy obesity” [36] and low cardiorespiratory fitness is
an independent predictor of all-cause and cardiovascular
disease mortality [37]. In consideration of this, the emphasis
for behavior change in this population should arguably be
on adopting and adhering to structured exercise programs,
cognizant of individual barriers to participation in exercise
and exercise preferences, which may require facilitation with
behavioral management strategies.
Obesity in developed nations is linked with an obeso-
genic environment which encompasses a calorie-dense diet
(overnutrition) and a physical activity hostile (or physical
inactivity-promoting) environment. However, while both
physical inactivity and excess adiposity are independently
associated with a greater risk of mortality [38], it is con-
tentious whether physical inactivity is a cause or an effect
of obesity [39, 40]. Therefore, while it is established that low
amounts of physical activity and high amounts of sedentary
behavior predict mortality [41], the role of these behaviors in
the development of abdominal obesity and liver fat is unclear
and perhaps minimal.
Recent research has suggested that prolonged sitting
(≥8 hours/day) is associated with an increased risk of all-
cause mortality [41, 42] and type 2 diabetes [42]. However,
in support of our findings, the association between sedentary
behavior and markers of cardiometabolic risk disappear
when adjusted [43] ormodified [42] for total physical activity
levels. Hence only individuals with low activity and high lev-
els of sedentary behavior such as sitting may be at increased
health risk [44]. While there is a heightened understanding
of the detrimental effects of increased sedentary behavior and
sitting time [42, 45] and interrupting sitting time may confer
some health benefit, this study suggests that a direct link
between unstructured, objectivelymeasured levels of physical
activity and sedentariness and levels of metabolically risky fat
depots is insignificant.
In concordance with these findings, despite significant
associations with moderate-to-vigorous physical activity, no
associations were observed between objectively quantified
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Table 4: Hierarchical regression model for prediction of liver fat.
𝑅 𝑅
2 Adjusted 𝑅2 𝑅2 change 𝑝 𝛽
Block 1 0.550 0.303 0.276 0.303 <0.001
Sex 0.102
Age 0.026
Waist 0.575
Block 2 0.630 0.397 0.331 0.094 0.055
Sex 0.176
Age 0.114
Waist 0.471
Glucose 0.23
HDL −0.162
ALT 0.104
BMI −0.146
Insulin 0.256
Block 3 0.632 0.400 0.305 0.003 0.957
Sex 0.166
Age 0.136
Waist 0.481
Glucose 0.008
HDL −0.180
ALT 0.105
BMI −0.165
Insulin 0.260
Sedentary 0.059
Moderate 0.000
Vigorous 0.046
BMI: body mass index; ALT: alanine aminotransferase; and HDL: high density lipoprotein cholesterol. Boldface indicates statistical significance (𝑝 < 0.05).
sedentary time and hepatic steatosis (estimated via CT) in
adults with NAFLD [23] or with VAT volume in men or
women [46]. A large analysis in 3056 volunteers observed
that individuals with NAFLD (defined by the fatty liver index
[47]) spent less time in light, moderate, or vigorous activity
than non-NAFLD counterparts and that the lowest quartile
of physical activity was found in individuals with NAFLD
and comorbid type 2 diabetes [22]. It has also been observed
that individuals meeting 150minutes/week of moderate-
to-vigorous physical activity as assessed via accelerometry
had the lowest odds of hepatic steatosis (assessed via CT)
independent of BMI (OR 0.77) [23]. However, in these
investigations, it is unclear whether the low levels of physical
activity caused the elevated liver fat content or whether
NAFLD itself caused patients to have low participation in
physical activity.
A limitation of this cross-sectional analysis is that the
non-NAFLD cohort had low mean liver fat levels which
reduced the range in the data. An important consideration
is that we recruited adults with overweight/obesity who had
no known comorbid cardiovascular or metabolic disease,
which probably contributed to this limited spread. Further
research examining the interaction between sedentary behav-
ior, physical activity levels, and metabolically detrimental
fat depots, employing gold-standard methods, across a more
diverse population, is therefore warranted. Another limita-
tion is that the aforementioned associations between physical
activity, fitness, and NAFLD may not translate to disease
severity. A retrospective analysis of 813 adults with biopsy-
proven NAFLD demonstrating that only those who reported
meeting theminimal guidelines for vigorous intensity activity
(≥75min/week) and not moderate physical activity guide-
lines (150 to ≥300min/week) reduced the odds of devel-
oping NASH (OR 0.65) with further reduced odds (OR
0.56) when the extensive guidelines for vigorous intensity
activity (≥150min/week) were met. Furthermore, the odds
of advanced fibrosis were only reduced in patients meeting
the extensive guidelines for vigorous activity [48]. These data
suggest that vigorous activity per se may be necessary for
improvements in the progressive forms of NAFLD although
longitudinal data from clinical trials are lacking and limited
by the invasive nature of liver biopsy to inform disease
severity.
In conclusion, there were no associations between seden-
tary behavior and levels of IHL or VAT and low levels
of objectively measured physical activity did not predict
high levels of VAT or IHL. These findings suggest that
while traditional risk factors such as waist circumference,
triglycerides, fasting glucose, or fasting insulin may predict
the incidence of NAFLD or high levels of VAT, objectively
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quantified physical activity levels and sedentary behavior did
not predict those at risk.
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